parallel randomized trial
NCT04440345
Multiple Ascending Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of IBI362 in Overweight or Obese Subjects
Design
Conduct and analysis
Arms
| Arm | Treatment | Background | Randomized | Analyzed | Completed treatment |
|---|---|---|---|---|---|
| A1 | Mazdutide 3 mg subcutaneous once weekly IBI362 3.0 mg cohort | lifestyle: none | 8 | 8 | |
| A10 | Mazdutide 9 mg subcutaneous once weekly Mazdutide 9 mg cohort | lifestyle: none | 8 | 8 | 8 |
| A11 | Placebo Placebo 9 mg cohort | lifestyle: none | 4 | 4 | 4 |
| A12 | Pooled Pooled placebo 9 and 10 mg cohorts | lifestyle: none | 8 | ||
| A13 | Pooled Pooled IBI362 3.0 to 6.0 mg cohorts | lifestyle: none | 24 | ||
| A2 | Placebo Placebo 3.0 mg cohort | lifestyle: none | 4 | 4 | |
| A3 | Mazdutide 4.5 mg subcutaneous once weekly IBI362 4.5 mg cohort | lifestyle: none | 8 | 8 | |
| A4 | Placebo Placebo 4.5 mg cohort | lifestyle: none | 4 | 4 | |
| A5 | Mazdutide 6 mg subcutaneous once weekly IBI362 6.0 mg cohort | lifestyle: none | 8 | 8 | |
| A6 | Placebo Placebo 6.0 mg cohort | lifestyle: none | 4 | 4 | |
| A7 | Pooled Pooled placebo 3.0 to 6.0 mg cohorts | lifestyle: none | 12 | ||
| A8 | mazdutide Mazdutide 10 mg cohort | lifestyle: none | 8 | 8 | 7 |
| A9 | Placebo Placebo 10 mg cohort | lifestyle: none | 4 | 4 | 2 |
Baseline characteristics
As printed in the trial reports or registry, per arm or for the whole trial.
| Characteristic | Statistic | Mazdutide 3 mg subcutaneous once weekly A1 | Placebo A2 | Mazdutide 4.5 mg subcutaneous once weekly A3 | Placebo A4 | Mazdutide 6 mg subcutaneous once weekly A5 | Placebo A6 | Pooled A7 | Mazdutide 10 mg cohort A8 | Placebo A9 | Mazdutide 9 mg subcutaneous once weekly A10 | Placebo A11 | Pooled A12 | Pooled A13 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| age | mean (years) | 36.0 | 34.3 | 37.9 | 45.5 | |||||||||
| age | median (years) | 29.5 | 39.5 | 31.0 | 37.0 | 40.0 | 32.0 | |||||||
| age | q1 (years) | 24.0 | 31.0 | 23.5 | 32.5 | 23.0 | 28.5 | |||||||
| age | q3 (years) | 45.0 | 43.5 | 33.0 | 43.0 | 51.5 | 34.5 | |||||||
| age | sd (years) | 9.1 | 14.0 | 9.7 | 6.4 | |||||||||
| asian | n | 8 | 4 | 8 | 4 | 8 | 4 | |||||||
| asian | percent | 100.0 | 100.0 | 100.0 | 100.0 | 100.0 | 100.0 | |||||||
| bmi: 24 to less than 28 | n | 2 | 0 | 1 | 1 | 0 | 3 | |||||||
| bmi: 24 to less than 28 | percent | 25.0 | 0 | 12.5 | 25.0 | 0 | 75.0 | |||||||
| bmi: 28 or more | n | 6 | 4 | 7 | 3 | 8 | 1 | |||||||
| bmi: 28 or more | percent | 75.0 | 100.0 | 87.5 | 75.0 | 100 | 25.0 | |||||||
| bmi | mean (kg/m2) | 29.3 | 30.6 | 32.4 | 29.1 | 31.7 | 29.0 | 31.8 | 29.1 | 30.1 | 30.1 | |||
| bmi | sd (kg/m2) | 2.2 | 1.2 | 3.4 | 3.7 | 2.0 | 5.1 | 5.1 | 4.6 | 3.8 | 1.7 | |||
| female | n | 5 | 3 | 2 | 2 | 3 | 3 | 6 | 3 | 6 | 2 | |||
| female | percent | 62.5 | 75.0 | 25.0 | 50.0 | 37.5 | 75.0 | 75.0 | 75.0 | 75.0 | 50.0 | |||
| waist | mean (cm) | 93.4 | 95.1 | 105.1 | 98.1 | 104.8 | 90.1 | 101.1 | 95.0 | 97.2 | 105.1 | |||
| waist | sd (cm) | 8.9 | 2.0 | 8.0 | 10.5 | 10.2 | 14.9 | 11.5 | 11.7 | 13.7 | 7.7 | |||
| weight | mean (kg) | 78.3 | 81.7 | 93.1 | 82.7 | 87.4 | 76.5 | 82.8 | 77.2 | 79.8 | 83.6 | |||
| weight | sd (kg) | 13.7 | 3.3 | 9.9 | 13.7 | 8.8 | 21.5 | 14.1 | 18.6 | 15.5 | 7.3 |
Results
198 adjudicated result lines, grouped by outcome. Open an outcome to see its values.
Systolic blood pressure change (4 lines; O05)
| Week | Arm | Statistic | Estimate | SE or SD | 95% CI | Events / N | Detail |
|---|---|---|---|---|---|---|---|
| 12 | A1 | change | -8.26 mmHg | -14.77 to -1.76 | 8 | not stated; modified itt; R0014885:Table 4 | |
| 12 | A3 | change | -5.80 mmHg | -12.34 to 0.73 | 8 | not stated; modified itt; R0014885:Table 4 | |
| 12 | A5 | change | -5.59 mmHg | -12.56 to 1.38 | 7 | not stated; modified itt; R0014885:Table 4 | |
| 12 | A7 | change | 2.02 mmHg | -3.40 to 7.44 | 12 | not stated; modified itt; R0014885:Table 4 |
Percent body weight change (13 lines; O10)
| Week | Arm | Statistic | Estimate | SE or SD | 95% CI | Events / N | Detail |
|---|---|---|---|---|---|---|---|
| 12 | A1 | percent change | -4.81 percent | -6.61 to -3.02 | 8 | not stated; modified itt; R0014885:Table 4 | |
| 12 | A1 vs A7 | md | -5.42 percent | -7.71 to -3.12 | not stated; modified itt; R0014885:Table 4 | ||
| 12 | A10 | percent change | -11.7 percent | 1.5 | not stated; modified itt; R0013351:Table 4 | ||
| 12 | A10 vs A12 | md | -9.8 percent | -14.4 to -5.3 | not stated; modified itt; R0013351:Table 4 | ||
| 12 | A12 | percent change | -1.8 percent | 1.6 | not stated; modified itt; R0013351:Table 4 | ||
| 12 | A3 | percent change | -6.40 percent | -8.23 to -4.58 | 8 | not stated; modified itt; R0014885:Table 4 | |
| 12 | A3 vs A7 | md | -7.01 percent | -9.39 to -4.63 | not stated; modified itt; R0014885:Table 4 | ||
| 12 | A5 | percent change | -6.05 percent | -7.91 to -4.18 | 7 | not stated; modified itt; R0014885:Table 4 | |
| 12 | A5 vs A7 | md | -6.65 percent | -9.03 to -4.27 | not stated; modified itt; R0014885:Table 4 | ||
| 12 | A7 | percent change | 0.60 percent | -0.86 to 2.07 | 12 | not stated; modified itt; R0014885:Table 4 | |
| 16 | A12 | percent change | -3.3 percent | 1.9 | not stated; modified itt; R0013351:Table 4 | ||
| 16 | A8 | percent change | -9.5 percent | 1.7 | not stated; modified itt; R0013351:Table 4 | ||
| 16 | A8 vs A12 | md | -6.2 percent | -11.5 to -0.9 | not stated; modified itt; R0013351:Table 4 |
Weight loss of 5 percent or more (4 lines; O11A)
| Week | Arm | Statistic | Estimate | SE or SD | 95% CI | Events / N | Detail |
|---|---|---|---|---|---|---|---|
| 12 | A11 | responders | 0 / 4 | not stated; modified itt; R0013351:Results | |||
| 12 | A13 | responders | 13 / 24 | not stated; modified itt; R0014885:Results | |||
| 12 | A7 | responders | 0 / 12 | not stated; modified itt; R0014885:Results | |||
| 16 | A9 | responders | 0 / 4 | not stated; modified itt; R0013351:Results |
Weight loss of 10 percent or more (5 lines; O11B)
| Week | Arm | Statistic | Estimate | SE or SD | 95% CI | Events / N | Detail |
|---|---|---|---|---|---|---|---|
| 12 | A10 | responders | 4 / 8 | not stated; modified itt; R0013351:Results | |||
| 12 | A11 | responders | 0 / 4 | not stated; modified itt; R0013351:Results | |||
| 12 | A7 | responders | 0 / 12 | not stated; modified itt; R0014885:Results | |||
| 16 | A8 | responders | 4 / 8 | not stated; modified itt; R0013351:Results | |||
| 16 | A9 | responders | 0 / 4 | not stated; modified itt; R0013351:Results |
Weight loss of 15 percent or more (5 lines; O11C)
| Week | Arm | Statistic | Estimate | SE or SD | 95% CI | Events / N | Detail |
|---|---|---|---|---|---|---|---|
| 12 | A10 | responders | 2 / 8 | not stated; modified itt; R0013351:Results | |||
| 12 | A11 | responders | 0 / 4 | not stated; modified itt; R0013351:Results | |||
| 12 | A7 | responders | 0 / 12 | not stated; modified itt; R0014885:Results | |||
| 16 | A8 | responders | 2 / 8 | not stated; modified itt; R0013351:Results | |||
| 16 | A9 | responders | 0 / 4 | not stated; modified itt; R0013351:Results |
Acute kidney injury (4 lines; O121)
| Week | Arm | Statistic | Estimate | SE or SD | 95% CI | Events / N | Detail |
|---|---|---|---|---|---|---|---|
| A2 | events | 0 / 4 | not stated; safety; R0014885:Supplement Table S2 | ||||
| A4 | events | 0 / 4 | not stated; safety; R0014885:Supplement Table S2 | ||||
| A5 | events | 0 / 8 | not stated; safety; R0014885:Supplement Table S2 | ||||
| A6 | events | 0 / 4 | not stated; safety; R0014885:Supplement Table S2 |
All cause mortality (10 lines; O20)
| Week | Arm | Statistic | Estimate | SE or SD | 95% CI | Events / N | Detail |
|---|---|---|---|---|---|---|---|
| A1 | events | 0 / 8 | not stated; safety; R0014885:Table 2 | ||||
| A10 | events | 0 / 8 | not stated; safety; R0013351:Table 2 | ||||
| A11 | events | 0 / 4 | not stated; safety; R0013351:Table 2 | ||||
| A2 | events | 0 / 4 | not stated; safety; R0014885:Table 2 | ||||
| A3 | events | 0 / 8 | not stated; safety; R0014885:Table 2 | ||||
| A4 | events | 0 / 4 | not stated; safety; R0014885:Table 2 | ||||
| A5 | events | 0 / 8 | not stated; safety; R0014885:Table 2 | ||||
| A6 | events | 0 / 4 | not stated; safety; R0014885:Table 2 | ||||
| A8 | events | 0 / 8 | not stated; safety; R0013351:Table 2 | ||||
| A9 | events | 0 / 4 | not stated; safety; R0013351:Table 2 |
Hospitalization for heart failure (10 lines; O23)
| Week | Arm | Statistic | Estimate | SE or SD | 95% CI | Events / N | Detail |
|---|---|---|---|---|---|---|---|
| A1 | events | 0 / 8 | not stated; safety; R0014885:Table 2 | ||||
| A10 | events | 0 / 8 | not stated; safety; R0013351:Table 2 | ||||
| A11 | events | 0 / 4 | not stated; safety; R0013351:Table 2 | ||||
| A2 | events | 0 / 4 | not stated; safety; R0014885:Table 2 | ||||
| A3 | events | 0 / 8 | not stated; safety; R0014885:Table 2 | ||||
| A4 | events | 0 / 4 | not stated; safety; R0014885:Table 2 | ||||
| A5 | events | 0 / 8 | not stated; safety; R0014885:Table 2 | ||||
| A6 | events | 0 / 4 | not stated; safety; R0014885:Table 2 | ||||
| A8 | events | 0 / 8 | not stated; safety; R0013351:Table 2 | ||||
| A9 | events | 0 / 4 | not stated; safety; R0013351:Table 2 |
Heart failure events (6 lines; O23B)
| Week | Arm | Statistic | Estimate | SE or SD | 95% CI | Events / N | Detail |
|---|---|---|---|---|---|---|---|
| A11 | events | 0 / 4 | not stated; safety; R0013351:Supplement Table S1 | ||||
| A2 | events | 0 / 4 | not stated; safety; R0014885:Supplement Table S2 | ||||
| A4 | events | 0 / 4 | not stated; safety; R0014885:Supplement Table S2 | ||||
| A5 | events | 0 / 8 | not stated; safety; R0014885:Supplement Table S2 | ||||
| A6 | events | 0 / 4 | not stated; safety; R0014885:Supplement Table S2 | ||||
| A8 | events | 0 / 8 | not stated; safety; R0013351:Supplement Table S1 |
Serious adverse events (10 lines; O25)
| Week | Arm | Statistic | Estimate | SE or SD | 95% CI | Events / N | Detail |
|---|---|---|---|---|---|---|---|
| A1 | events | 0 / 8 | not stated; safety; R0014885:Table 2 | ||||
| A10 | events | 0 / 8 | not stated; safety; R0013351:Table 2 | ||||
| A11 | events | 0 / 4 | not stated; safety; R0013351:Table 2 | ||||
| A2 | events | 0 / 4 | not stated; safety; R0014885:Table 2 | ||||
| A3 | events | 0 / 8 | not stated; safety; R0014885:Table 2 | ||||
| A4 | events | 0 / 4 | not stated; safety; R0014885:Table 2 | ||||
| A5 | events | 0 / 8 | not stated; safety; R0014885:Table 2 | ||||
| A6 | events | 0 / 4 | not stated; safety; R0014885:Table 2 | ||||
| A8 | events | 0 / 8 | not stated; safety; R0013351:Table 2 | ||||
| A9 | events | 0 / 4 | not stated; safety; R0013351:Table 2 |
Discontinuation due to adverse events (16 lines; O26)
| Week | Arm | Statistic | Estimate | SE or SD | 95% CI | Events / N | Detail |
|---|---|---|---|---|---|---|---|
| A1 | events | 0 / 8 | not stated; safety; R0014885:Abstract | ||||
| A1 | events | 0 / 8 | not stated; safety; R0014885:Results | ||||
| A10 | events | 0 / 8 | not stated; safety; R0013351:Table 2 | ||||
| A11 | events | 0 / 4 | not stated; safety; R0013351:Table 2 | ||||
| A2 | events | 0 / 4 | not stated; safety; R0014885:Results | ||||
| A2 | events | 0 / 4 | not stated; safety; R0014885:Abstract | ||||
| A3 | events | 0 / 8 | not stated; safety; R0014885:Abstract | ||||
| A3 | events | 0 / 8 | not stated; safety; R0014885:Results | ||||
| A4 | events | 0 / 4 | not stated; safety; R0014885:Abstract | ||||
| A4 | events | 0 / 4 | not stated; safety; R0014885:Results | ||||
| A5 | events | 0 / 8 | not stated; safety; R0014885:Results | ||||
| A5 | events | 0 / 8 | not stated; safety; R0014885:Abstract | ||||
| A6 | events | 0 / 4 | not stated; safety; R0014885:Abstract | ||||
| A6 | events | 0 / 4 | not stated; safety; R0014885:Results | ||||
| A8 | events | 0 / 8 | not stated; safety; R0013351:Table 2 | ||||
| A9 | events | 0 / 4 | not stated; safety; R0013351:Table 2 |
Nausea (10 lines; O27A)
| Week | Arm | Statistic | Estimate | SE or SD | 95% CI | Events / N | Detail |
|---|---|---|---|---|---|---|---|
| A1 | events | 0 / 8 | not stated; safety; R0014885:Table 2 | ||||
| A10 | events | 5 / 8 | not stated; safety; R0013351:Table 2 | ||||
| A11 | events | 0 / 4 | not stated; safety; R0013351:Table 2 | ||||
| A2 | events | 0 / 4 | not stated; safety; R0014885:Table 2 | ||||
| A3 | events | 3 / 8 | not stated; safety; R0014885:Table 2 | ||||
| A4 | events | 1 / 4 | not stated; safety; R0014885:Table 2 | ||||
| A5 | events | 1 / 8 | not stated; safety; R0014885:Table 2 | ||||
| A6 | events | 0 / 4 | not stated; safety; R0014885:Table 2 | ||||
| A8 | events | 1 / 8 | not stated; safety; R0013351:Table 2 | ||||
| A9 | events | 1 / 4 | not stated; safety; R0013351:Table 2 |
Vomiting (10 lines; O27B)
| Week | Arm | Statistic | Estimate | SE or SD | 95% CI | Events / N | Detail |
|---|---|---|---|---|---|---|---|
| A1 | events | 1 / 8 | not stated; safety; R0014885:Table 2 | ||||
| A10 | events | 3 / 8 | not stated; safety; R0013351:Table 2 | ||||
| A11 | events | 0 / 4 | not stated; safety; R0013351:Table 2 | ||||
| A2 | events | 0 / 4 | not stated; safety; R0014885:Table 2 | ||||
| A3 | events | 0 / 8 | not stated; safety; R0014885:Table 2 | ||||
| A4 | events | 0 / 4 | not stated; safety; R0014885:Table 2 | ||||
| A5 | events | 1 / 8 | not stated; safety; R0014885:Table 2 | ||||
| A6 | events | 0 / 4 | not stated; safety; R0014885:Table 2 | ||||
| A8 | events | 3 / 8 | not stated; safety; R0013351:Table 2 | ||||
| A9 | events | 0 / 4 | not stated; safety; R0013351:Table 2 |
Diarrhea (10 lines; O27C)
| Week | Arm | Statistic | Estimate | SE or SD | 95% CI | Events / N | Detail |
|---|---|---|---|---|---|---|---|
| A1 | events | 0 / 8 | not stated; safety; R0014885:Table 2 | ||||
| A10 | events | 2 / 8 | not stated; safety; R0013351:Table 2 | ||||
| A11 | events | 2 / 4 | not stated; safety; R0013351:Table 2 | ||||
| A2 | events | 0 / 4 | not stated; safety; R0014885:Table 2 | ||||
| A3 | events | 3 / 8 | not stated; safety; R0014885:Table 2 | ||||
| A4 | events | 1 / 4 | not stated; safety; R0014885:Table 2 | ||||
| A5 | events | 3 / 8 | not stated; safety; R0014885:Table 2 | ||||
| A6 | events | 0 / 4 | not stated; safety; R0014885:Table 2 | ||||
| A8 | events | 4 / 8 | not stated; safety; R0013351:Table 2 | ||||
| A9 | events | 2 / 4 | not stated; safety; R0013351:Table 2 |
Constipation (10 lines; O27D)
| Week | Arm | Statistic | Estimate | SE or SD | 95% CI | Events / N | Detail |
|---|---|---|---|---|---|---|---|
| A1 | events | 1 / 8 | not stated; safety; R0014885:Table 2 | ||||
| A10 | events | 1 / 8 | not stated; safety; R0013351:Supplement Table S1 | ||||
| A11 | events | 0 / 4 | not stated; safety; R0013351:Supplement Table S1 | ||||
| A2 | events | 0 / 4 | not stated; safety; R0014885:Table 2 | ||||
| A3 | events | 0 / 8 | not stated; safety; R0014885:Table 2 | ||||
| A4 | events | 0 / 4 | not stated; safety; R0014885:Table 2 | ||||
| A5 | events | 0 / 8 | not stated; safety; R0014885:Table 2 | ||||
| A6 | events | 1 / 4 | not stated; safety; R0014885:Table 2 | ||||
| A8 | events | 0 / 8 | not stated; safety; R0013351:Supplement Table S1 | ||||
| A9 | events | 0 / 4 | not stated; safety; R0013351:Supplement Table S1 |
Discontinuation due to gastrointestinal adverse events (16 lines; O27E)
| Week | Arm | Statistic | Estimate | SE or SD | 95% CI | Events / N | Detail |
|---|---|---|---|---|---|---|---|
| A1 | events | 0 / 8 | not stated; safety; R0014885:Results | ||||
| A1 | events | 0 / 8 | not stated; safety; R0014885:Abstract | ||||
| A10 | events | 0 / 8 | not stated; safety; R0013351:Table 2 | ||||
| A11 | events | 0 / 4 | not stated; safety; R0013351:Table 2 | ||||
| A2 | events | 0 / 4 | not stated; safety; R0014885:Abstract | ||||
| A2 | events | 0 / 4 | not stated; safety; R0014885:Results | ||||
| A3 | events | 0 / 8 | not stated; safety; R0014885:Results | ||||
| A3 | events | 0 / 8 | not stated; safety; R0014885:Abstract | ||||
| A4 | events | 0 / 4 | not stated; safety; R0014885:Results | ||||
| A4 | events | 0 / 4 | not stated; safety; R0014885:Abstract | ||||
| A5 | events | 0 / 8 | not stated; safety; R0014885:Results | ||||
| A5 | events | 0 / 8 | not stated; safety; R0014885:Abstract | ||||
| A6 | events | 0 / 4 | not stated; safety; R0014885:Abstract | ||||
| A6 | events | 0 / 4 | not stated; safety; R0014885:Results | ||||
| A8 | events | 0 / 8 | not stated; safety; R0013351:Table 2 | ||||
| A9 | events | 0 / 4 | not stated; safety; R0013351:Table 2 |
Gallbladder and biliary disease (4 lines; O28)
| Week | Arm | Statistic | Estimate | SE or SD | 95% CI | Events / N | Detail |
|---|---|---|---|---|---|---|---|
| A10 | events | 1 / 8 | not stated; safety; cholelithiasis; R0013351:Supplement Table S1 | ||||
| A11 | events | 0 / 4 | not stated; safety; cholelithiasis; R0013351:Supplement Table S1 | ||||
| A8 | events | 0 / 8 | not stated; safety; cholelithiasis; R0013351:Supplement Table S1 | ||||
| A9 | events | 0 / 4 | not stated; safety; cholelithiasis; R0013351:Supplement Table S1 |
Acute pancreatitis (10 lines; O29)
| Week | Arm | Statistic | Estimate | SE or SD | 95% CI | Events / N | Detail |
|---|---|---|---|---|---|---|---|
| A1 | events | 0 / 8 | not stated; safety; pancreatitis; R0014885:Results | ||||
| A10 | events | 0 / 8 | not stated; safety; pancreatitis; R0013351:Results | ||||
| A11 | events | 0 / 4 | not stated; safety; pancreatitis; R0013351:Results | ||||
| A2 | events | 0 / 4 | not stated; safety; pancreatitis; R0014885:Results | ||||
| A3 | events | 0 / 8 | not stated; safety; pancreatitis; R0014885:Results | ||||
| A4 | events | 0 / 4 | not stated; safety; pancreatitis; R0014885:Results | ||||
| A5 | events | 0 / 8 | not stated; safety; pancreatitis; R0014885:Results | ||||
| A6 | events | 0 / 4 | not stated; safety; pancreatitis; R0014885:Results | ||||
| A8 | events | 0 / 8 | not stated; safety; pancreatitis; R0013351:Results | ||||
| A9 | events | 0 / 4 | not stated; safety; pancreatitis; R0013351:Results |
Medullary thyroid carcinoma (10 lines; O32A)
| Week | Arm | Statistic | Estimate | SE or SD | 95% CI | Events / N | Detail |
|---|---|---|---|---|---|---|---|
| A1 | events | 0 / 8 | not stated; safety; R0014885:Results | ||||
| A10 | events | 0 / 8 | not stated; safety; R0013351:Results | ||||
| A11 | events | 0 / 4 | not stated; safety; R0013351:Results | ||||
| A2 | events | 0 / 4 | not stated; safety; R0014885:Results | ||||
| A3 | events | 0 / 8 | not stated; safety; R0014885:Results | ||||
| A4 | events | 0 / 4 | not stated; safety; R0014885:Results | ||||
| A5 | events | 0 / 8 | not stated; safety; R0014885:Results | ||||
| A6 | events | 0 / 4 | not stated; safety; R0014885:Results | ||||
| A8 | events | 0 / 8 | not stated; safety; R0013351:Results | ||||
| A9 | events | 0 / 4 | not stated; safety; R0013351:Results |
Thyroid cancer (any) (10 lines; O32B)
| Week | Arm | Statistic | Estimate | SE or SD | 95% CI | Events / N | Detail |
|---|---|---|---|---|---|---|---|
| A1 | events | 0 / 8 | not stated; safety; R0014885:Results | ||||
| A10 | events | 0 / 8 | not stated; safety; R0013351:Results | ||||
| A11 | events | 0 / 4 | not stated; safety; R0013351:Results | ||||
| A2 | events | 0 / 4 | not stated; safety; R0014885:Results | ||||
| A3 | events | 0 / 8 | not stated; safety; R0014885:Results | ||||
| A4 | events | 0 / 4 | not stated; safety; R0014885:Results | ||||
| A5 | events | 0 / 8 | not stated; safety; R0014885:Results | ||||
| A6 | events | 0 / 4 | not stated; safety; R0014885:Results | ||||
| A8 | events | 0 / 8 | not stated; safety; R0013351:Results | ||||
| A9 | events | 0 / 4 | not stated; safety; R0013351:Results |
Nonarteritic anterior ischemic optic neuropathy (3 lines; O34)
| Week | Arm | Statistic | Estimate | SE or SD | 95% CI | Events / N | Detail |
|---|---|---|---|---|---|---|---|
| A10 | events | 0 / 8 | not stated; safety; R0013351:Supplement Table S1 | ||||
| A11 | events | 0 / 4 | not stated; safety; R0013351:Supplement Table S1 | ||||
| A9 | events | 0 / 4 | not stated; safety; R0013351:Supplement Table S1 |
Suicidal ideation or behavior (8 lines; O35A)
| Week | Arm | Statistic | Estimate | SE or SD | 95% CI | Events / N | Detail |
|---|---|---|---|---|---|---|---|
| A1 | events | 0 / 8 | not stated; safety; R0014885:Supplement Table S2 | ||||
| A11 | events | 0 / 4 | not stated; safety; R0013351:Supplement Table S1 | ||||
| A2 | events | 0 / 4 | not stated; safety; R0014885:Supplement Table S2 | ||||
| A4 | events | 0 / 4 | not stated; safety; R0014885:Supplement Table S2 | ||||
| A5 | events | 0 / 8 | not stated; safety; R0014885:Supplement Table S2 | ||||
| A6 | events | 0 / 4 | not stated; safety; R0014885:Supplement Table S2 | ||||
| A8 | events | 0 / 8 | not stated; safety; R0013351:Supplement Table S1 | ||||
| A9 | events | 0 / 4 | not stated; safety; R0013351:Supplement Table S1 |
Death by suicide (10 lines; O35B)
| Week | Arm | Statistic | Estimate | SE or SD | 95% CI | Events / N | Detail |
|---|---|---|---|---|---|---|---|
| A1 | events | 0 / 8 | not stated; safety; R0014885:Table 2 | ||||
| A10 | events | 0 / 8 | not stated; safety; R0013351:Table 2 | ||||
| A11 | events | 0 / 4 | not stated; safety; R0013351:Table 2 | ||||
| A2 | events | 0 / 4 | not stated; safety; R0014885:Table 2 | ||||
| A3 | events | 0 / 8 | not stated; safety; R0014885:Table 2 | ||||
| A4 | events | 0 / 4 | not stated; safety; R0014885:Table 2 | ||||
| A5 | events | 0 / 8 | not stated; safety; R0014885:Table 2 | ||||
| A6 | events | 0 / 4 | not stated; safety; R0014885:Table 2 | ||||
| A8 | events | 0 / 8 | not stated; safety; R0013351:Table 2 | ||||
| A9 | events | 0 / 4 | not stated; safety; R0013351:Table 2 |